Multimodal treatment with curative intent in a germline BRCA2 mutant metastatic ampullary adenocarcinoma: a case report
Abstract Background Cancers of the Vater ampulla (ampullary cancers, ACs) account for less than 1% of all gastrointestinal tumors. ACs are usually diagnosed at advanced stage, with poor prognosis and limited therapeutic options. BRCA2 mutations are identified in up to 14% of ACs and, differently fro...
Main Authors: | Gianluca Mauri, Viviana Gori, Giorgio Patelli, Laura Roazzi, Francesco Rizzetto, Luciano De Carlis, Anna Mariani, Ugo Cavallari, Elisabetta Prada, Tiziana Cipani, Maria Costanza Aquilano, Emanuela Bonoldi, Angelo Vanzulli, Salvatore Siena, Andrea Sartore-Bianchi |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-03-01
|
Series: | World Journal of Surgical Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12957-023-02976-0 |
Similar Items
-
Current Status of Endoscopic Papillectomy for Ampullary Tumors
Published: (2014-11-01) -
Updates on the Management of Ampullary Neoplastic Lesions
by: Roberta Maselli, et al.
Published: (2023-10-01) -
Management of Ampullary Carcinoid Tumors with Pancreaticoduodenectomy
by: Wassim Abi Jaoude, et al.
Published: (2010-10-01) -
Surgical treatment of duodenal adenocarcinoma: ampullary vs. non-ampullary, short- and long-term outcomes
by: Jana Tesarikova, et al.
Published: (2022-09-01) -
Imaging of Ampullary and Periampullary Conditions
by: Abhijit Sunnapwar, et al.
Published: (2021-05-01)